Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Charcot-Marie-Tooth disease type 4B2 (CMT4B2) is a subtype of Charcot-Marie-Tooth type 4 characterized by a severe, early childhood-onset of demyelinating sensorimotor neuropathy, early-onset glaucoma, focally folded myelin sheaths in the peripheral nerves, severely reduced nerve conduction velocities, and the typical CMT phenotype (i.e. distal muscle weakness and atrophy, sensory loss, and frequent pes cavus). Severe visual impairment leading to visual loss has also been reported.
Features include always present findings: Distal muscle weakness; and very common findings: Difficulty walking (gait disturbance), Abnormal foot morphology, Areflexia of lower limbs, and Myelin outfoldings and others. 54 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Arms and legs | 13 | Split hand, Foot dorsiflexor weakness, Abnormal foot morphology |
Muscles | 12 | Distal muscle weakness, Foot dorsiflexor weakness, Lower limb muscle weakness |
Brain and nerves | 11 | Hyporeflexia, Steppage gait, Difficulty walking (gait disturbance) |
Eyes | 5 | Glaucoma, Ptosis, Cataract |
Bones and joints | 2 | Kyphoscoliosis, Sideways curvature of the spine (scoliosis) |
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
Lungs and breathing | 1 | Difficulty breathing (respiratory insufficiency) |
Head and neck | 1 | Weakness of facial musculature |
SBF2 function has not been fully characterized.
Charcot-Marie-Tooth disease type 4B2 is caused by mutations in the SBF2 gene on chromosome 11.
Genetic testing for SBF2 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 1 always present feature, 9 very common features, 10 common features.
Estimated prevalence: Unknown (Unknown prevalence).
2 clinical trials registered, 2 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
1 publication has been identified in PubMed for Charcot-Marie-Tooth disease type 4B2. Research spans Case Report / Case Series (100%).
Vengala A (2026). [PMID: 41766086](https://pubmed.ncbi.nlm.nih.gov/41766086/). *Journal of clinical neuromuscular disease*. [Case Report / Case Series]
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 2:57 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Charcot-Marie-Tooth disease type 4B2